![Brent Warner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Warner
Directeur Général chez
Protego Biopharma, Inc.
Profil
Brent J.
Warner is currently Chief Executive Officer & Director at Protego Biopharma, Inc. since 2024.
Formerly, Mr. Warner was President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024 and Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
Mr. Warner completed undergraduate and MBAistration degrees at Northwood University (Michigan).
Postes actifs de Brent Warner
| Sociétés | Poste | Début |
|---|---|---|
Protego Biopharma, Inc.
 Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur Général | 01/04/2024 |
Anciens postes connus de Brent Warner
| Sociétés | Poste | Fin |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2024 |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2022 |
Formation de Brent Warner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Northwood University (Michigan)
 Northwood University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
